Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

NVCTNVCT
Showing 8 of 18 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in NUVECTIS PHARMA INC

GEODE CAPITAL MANAGEMENT, LLC holds 432,273 shares of NVCT (NUVECTIS PHARMA INC), worth $8M as of 2026-Q2. The position was increased (+12.5% shares). NVCT represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$8M

Current Shares

432,273

Total Value Change

+$7.4M

Total Shares Change

+352,557

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
432,273
+12.5%
$8M0.0%$18.39
31
2026-Q1
Increased
384,105
+5.5%
$3M0.0%$8.71
28
2025-Q4
Increased
364,024
+11.8%
$2.7M0.0%$7.38
29
2025-Q3
Increased
325,733
+14.2%
$2M0.0%$5.92
29
2025-Q2
Increased
285,332
+110.8%
$2.1M0.0%$7.55
42
2025-Q1
Increased
135,333
+70.8%
$1.3M0.0%$10.46
38
2024-Q4
Decreased
79,243
-0.6%
$428,7770.0%$5.14
0
2024-Q3
Increased
79,716
+49.8%
$501,4810.0%$6.18
23

Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used